Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytoplasmic HAX1 Is an Independent Risk Factor for Breast Cancer Metastasis.
Trebinska-Stryjewska A, Szafron L, Rembiszewska A, Wakula M, Tabor S, Sienkiewicz R, Owczarek J, Balcerak A, Felisiak-Golabek A, Grzybowska EA. Trebinska-Stryjewska A, et al. Among authors: szafron l. J Oncol. 2019 Apr 10;2019:6375025. doi: 10.1155/2019/6375025. eCollection 2019. J Oncol. 2019. PMID: 31093284 Free PMC article.
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.
Szafron LM, Balcerak A, Grzybowska EA, Pienkowska-Grela B, Felisiak-Golabek A, Podgorska A, Kulesza M, Nowak N, Pomorski P, Wysocki J, Rubel T, Dansonka-Mieszkowska A, Konopka B, Lukasik M, Kupryjanczyk J. Szafron LM, et al. PLoS One. 2015 May 15;10(5):e0127475. doi: 10.1371/journal.pone.0127475. eCollection 2015. PLoS One. 2015. PMID: 25978564 Free PMC article.
The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.
Szafron LM, Balcerak A, Grzybowska EA, Pienkowska-Grela B, Podgorska A, Zub R, Olbryt M, Pamula-Pilat J, Lisowska KM, Grzybowska E, Rubel T, Dansonka-Mieszkowska A, Konopka B, Kulesza M, Lukasik M, Kupryjanczyk J. Szafron LM, et al. Oncotarget. 2015 Dec 22;6(41):43897-910. doi: 10.18632/oncotarget.6016. Oncotarget. 2015. PMID: 26556866 Free PMC article.
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.
Felisiak-Golabek A, Rembiszewska A, Rzepecka IK, Szafron L, Madry R, Murawska M, Napiorkowski T, Sobiczewski P, Osuch B, Kupryjanczyk J; Polish Ovarian Cancer Study Group (POCSG). Felisiak-Golabek A, et al. Among authors: szafron l. J Ovarian Res. 2011 Nov 10;4(1):20. doi: 10.1186/1757-2215-4-20. J Ovarian Res. 2011. PMID: 22075440 Free PMC article.
p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
Felisiak-Golabek A, Dansonka-Mieszkowska A, Rzepecka IK, Szafron L, Kwiatkowska E, Konopka B, Podgorska A, Rembiszewska A, Kupryjanczyk J. Felisiak-Golabek A, et al. Among authors: szafron l. Cancer Biol Ther. 2013 Oct 1;14(10):973-81. doi: 10.4161/cbt.25966. Epub 2013 Aug 14. Cancer Biol Ther. 2013. PMID: 24022213 Free PMC article.
The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.
Konopka B, Szafron LM, Kwiatkowska E, Podgorska A, Zolocinska A, Pienkowska-Grela B, Dansonka-Mieszkowska A, Balcerak A, Lukasik M, Stachurska A, Timorek A, Spiewankiewicz B, El-Bahrawy M, Kupryjanczyk J. Konopka B, et al. Oncotarget. 2016 Oct 11;7(41):67412-67424. doi: 10.18632/oncotarget.11822. Oncotarget. 2016. PMID: 27602952 Free PMC article.
Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.
Kupryjańczyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, Plisiecka-Hałasa J, Szafron L, Podgórska A, Rzepecka IK, Konopka B, Budziłowska A, Rembiszewska A, Grajkowska W, Spiewankiewicz B. Kupryjańczyk J, et al. Among authors: szafron l. Pol J Pathol. 2013 Dec;64(4):238-46. doi: 10.5114/pjp.2013.39331. Pol J Pathol. 2013. PMID: 24375037 Free article.
PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
Dansonka-Mieszkowska A, Szafron LA, Kulesza M, Stachurska A, Leszczynski P, Tomczyk-Szatkowska A, Sobiczewski P, Parada J, Kulinczak M, Moes-Sosnowska J, Pienkowska-Grela B, Kupryjanczyk J, Chechlinska M, Szafron LM. Dansonka-Mieszkowska A, et al. Among authors: szafron lm, szafron la. PLoS One. 2022 Jul 22;17(7):e0271539. doi: 10.1371/journal.pone.0271539. eCollection 2022. PLoS One. 2022. PMID: 35867729 Free PMC article.
30 results